51 articles with Bactiguard AB
Following successful European regulatory clearance and market launch of Bactiguard-coatedZimmer Biomet trauma implants, the initial USD 1 million milestone payment has been released.
A recently published, randomized, controlled multicenter study in India shows that urinary catheters with Bactiguard's coating for infection prevention reduce the risk of catheter-associated urinary tract infections by 69% compared to standard catheters.
Health Canada has approved Bactiguard's urinary catheter with temperature sensor for infection prevention through an Interim Order.
Cecilia Edström has informed the Board that she wishes to resign as CEO of Bactiguard Holding AB after seven years in the Executive Management team.
Bactiguard has received an initial order for coating concentrate from Well Lead Medical (Well Lead) in China . The order will be delivered promptly and generate license revenues in the fourth quarter 2020 of approximately SEK 9 million. In parallel with the marketing and sales of Bactiguard's BIP Foley urinary catheters in the C
Bactiguard presents updated financial targets for 2025 in connection with the company's financial report for the third quarter of 2020.
Bactiguard Holding AB, BACTI, has received orders from customers, including the Police Authority, at a total value of over SEK 20 million within the first few days of the launch of HYDROCYN aqua® on the Swedish market.
Bactiguard launches HYDROCYN aqua®, a water-based product that has been proven to have a powerful effect on killing previous variants of coronavirus within 15-30 seconds.
In the fight against the Corona virus, Bactiguard donates products for infection prevention to Chinese hospitals, at a market value of over 2 million SEK .
Bactiguard Holding AB (publ) ("Bactiguard") has completed the acquisition of Vigilenz Medical Devices and Vigilenz Medical Supplies (together Vigilenz), which was announced on 4 February 2020 .
A strong development in fourth quarter earnings, combined with the licensing deal with Zimmer Biomet led to the highest full-year result in Bactiguard's history.
Bactiguard deepens the partnership that was initiated in 2015 by acquiring Vigilenz Medical Devices and Vigilenz Medical Supplies in Malaysia.
Christian Kinch Resigns as CEO of Bactiguard and is Proposed as New Chairman of the Board. Cecilia Edström Appointed New CEO
Christian Kinch announced to the Board that he will resign as CEO of Bactiguard Holding AB after close to 16 years.
Bactiguard has received a new order from Well Lead Medical in China. The order will be delivered promptly and generate revenues in the fourth quarter of approximately SEK 16.5 million.
The members of the Nomination Committee for the Annual General Meeting of Bactiguard Holding AB (publ), to be held on Tuesday 28 April 2020 at the company’s headoffice in Botkyrka, have now been appoined.
Bactiguard has received a new order from Well Lead Medical (Well Lead) in China. The order will be delivered promptly and generate revenues in the third quarter of approximately SEK 4,8 million.
Bactiguard has entered into an exclusive, global license agreement for orthopedic trauma implants with Zimmer Biomet.
Bactiguard’s indwelling urinary catheters are now approved for reimbursement in the Netherlands, which means that healthcare providers in the home care market can provide patients with Bactiguard's products for infection prevention and improve their quality of life.
Stefan Grass with extensive clinical experience as a physician and researcher, combined with senior positions in the pharmaceutical industry, has been recruited to a newly established, global role as Chief Medical and Technology Officer.
The second quarter of 2019 was eventful. We increased our market coverage, secured funding for a very interesting research and development project, broadened the clinical evidence and strengthened executive management.